KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $172.3 million.

  • Bio-Rad Laboratories' Accumulated Expenses rose 3872.79% to $172.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $172.3 million, marking a year-over-year increase of 3872.79%. This contributed to the annual value of $172.3 million for FY2025, which is 3872.79% up from last year.
  • As of Q4 2025, Bio-Rad Laboratories' Accumulated Expenses stood at $172.3 million, which was up 3872.79% from $182.8 million recorded in Q3 2025.
  • Bio-Rad Laboratories' 5-year Accumulated Expenses high stood at $277.0 million for Q4 2021, and its period low was $124.2 million during Q4 2024.
  • Over the past 5 years, Bio-Rad Laboratories' median Accumulated Expenses value was $173.1 million (recorded in 2023), while the average stood at $175.0 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 2967.51% in 2022, then skyrocketed by 3872.79% in 2025.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Accumulated Expenses stood at $277.0 million in 2021, then fell by 29.68% to $194.8 million in 2022, then fell by 28.18% to $139.9 million in 2023, then decreased by 11.22% to $124.2 million in 2024, then surged by 38.73% to $172.3 million in 2025.
  • Its last three reported values are $172.3 million in Q4 2025, $182.8 million for Q3 2025, and $157.8 million during Q2 2025.